GCR-002 Feline Kidney Health Study

Health Markers
Before and After
Supplementation

Recruiting 60 cats · Healthy cats and cats with CKD at IRIS stages 1–3

Selected by study eligibility, not application order

Study supplement code: GCR-002

Apply for Your Cat

This study takes place in South Korea. Future studies may offer participation opportunities in more countries and regions.

Our research team will review your application and contact you about whether your cat is eligible.

TT, a Greycoat Research cat with stage 2 CKD
GREYCOAT RESEARCHTT · Stage 2 CKD
WHAT IS GCR-002?Inspired by long-term care for
TT, a cat with stage 2 CKD
The supplement evaluated in this study
STUDY OVERVIEW

Study at a Glance

Study population60cats

Healthy cats and cats with CKD at IRIS stages 1–3

Supplement schedule28days

Whole capsules, twice daily

Clinic visits2visits

In person, in South Korea

Participation
Whole capsules twice daily · Two clinic visits
Organizers
MomoGroup Co., Ltd. · Greycoat Research
Clinics
Taeneung Cat Specialty Animal Hospital · World Pet Animal Hospital · Soseol Cat Hospital and collaborating clinics
Study lead
Hochul Shin PhD

STUDY PRINCIPLES

Your Cat’s Health Comes First

Continue your cat’s existing treatment

Do not stop or change prescribed medications or a prescription diet on your own to take part in the study. Tell us about your cat’s current treatment when you apply.

We review each cat’s suitability individually

Our research team reviews your cat’s health, current treatment, and ability to take whole capsules to determine whether participation is appropriate.

Veterinary care takes priority

Your cat’s health and comfort come first throughout the study. If your cat needs veterinary care, that care takes priority over the study schedule or supplementation.

Long-Term Care for TT,
a Cat with Stage 2 CKD

GCR-002 is the product code for the supplement being evaluated in this study.

The formulation is based on key ingredients that TT, a cat with stage 2 CKD, has received over many years. This study compares test results before and after 28 days of supplementation.

One cat’s experience cannot establish whether a supplement or a particular ingredient is effective. This study examines changes in health markers before and after GCR-002 supplementation.

Eight years of creatinine test results for TT, a cat with stage 2 CKD
Creatinine test results for TT, a cat with stage 2 CKD, from October 2019 to May 2026, with an orange dashed trend line. Units: mg/dL.
TT, a cat with stage 2 CKD, running at home

Recent footage of TT, a cat with stage 2 CKD, running around at home (2026)

WHAT WE MEASURE

Comparing Health Markers
Before and After 28 Days

We compare blood test results before and after 28 days of GCR-002 supplementation. We examine markers related to kidney and liver health, as well as gene expression related to inflammation and metabolism.

RENAL

Kidney Health

Creatinine (CRE), blood urea nitrogen (BUN), SDMA, phosphorus (PHOS), and other markers.

LIVER

Liver Health

ALT, ALP, total bilirubin (TBIL), and other markers.

GENE EXPRESSION

Whole-Blood mRNA Analysis

Gene expression related to inflammation and metabolism, including IL1B, TNF, and SIRT1.

GENETIC TEST

Genetic Testing

Blood-type-related genetic information and information across 10 health categories, including AIM (CD5L) exon 3 analysis.

Genetic test results do not provide a definitive diagnosis or guarantee future health outcomes.

Which Cats
May Be Eligible?

Healthy cats and IRIS stages 1–3 60 cats

CKD means chronic kidney disease. IRIS stages are part of the International Renal Interest Society system that veterinarians use to assess CKD.

HEALTHY

Healthy

Current kidney test results may provide a reference for tracking future changes in health.

IRIS

Stage 1

Current kidney test results may help inform comparisons before and after the study and discussions about future care.

IRIS

Stage 2

We assess current kidney health and compare key test results before and after 28 days of supplementation.

IRIS

Stage 3

We carefully review current health, prescribed medications, prescription diets, and other treatment to determine whether participation is appropriate.

What Participation Involves

28days · twice daily

Give whole capsules twice daily

On days 1–28, give GCR-002 as whole capsules twice daily. Do not open the capsules or mix their contents into food.

2in-person visits

Visit a participating clinic in South Korea

Attend two in-person visits at a designated participating veterinary clinic in South Korea: baseline testing on day 0 and final testing on day 29 or a later date arranged with the research team.

Dailyrecords and health updates

Record doses and share health updates

Keep a daily supplementation record for 28 days and complete a brief health questionnaire twice a week. Report appetite, activity, vomiting, diarrhea, and any other changes. If your cat’s condition changes, contact the research team and your veterinary clinic without waiting for the next questionnaire.

Being able to give whole capsules twice daily for 28 days is an important requirement.

FROM APPLICATION TO COMPLETION

How the Study Works

Supplementation for 28 days
Two clinic visits in South Korea

  1. 01

    Apply

    Complete the online application.

  2. 02

    Eligibility Review

    Our team reviews your cat’s health, current treatment, and ability to take whole capsules.

  3. 03

    Participation Confirmation

    Review the study information and give your consent for your cat to participate.

  4. 04

    Day 0 · Veterinary Clinic Visit

    Your cat has a physical examination and baseline blood tests, and you receive GCR-002.

  5. 05

    Days 1–28 · At-Home Care

    Give the supplement twice daily, keep a daily supplementation record, and complete a health questionnaire twice a week.

  6. 06

    Day 29 or Later · Veterinary Clinic Visit

    Visit the clinic on day 29 or a later date arranged with the research team for final blood tests and genetic testing.

    If the final examination is delayed, contact the research team. Your veterinarian and the research team will advise whether supplementation should continue and when it should end. Do not extend the study period on your own.

  7. ✓

    Completion

    Receive an individual results report and the post-study support described below.

TESTS AND SUPPORT

Study Tests and
Supplement Support

Included study tests and GCR-002

The tests included in the study and the GCR-002 supplied for the study are provided at no charge. Separate terms apply to supplement vouchers provided after study completion.

01 / SUPPLEMENT

Study Supplement and Vouchers

GCR-002 and personalized supplement support

Selected cats receive a one-month supply of GCR-002. After study completion: Vouchers for 11 months of personalized supplement support are provided, subject to the stated voucher terms.

02 / BLOOD TEST

Blood Tests at Two Visits

Day 0 and the final visit

Testing includes kidney and liver health markers and whole-blood mRNA analysis.

03 / GENETIC TEST

Feline Genetic Testing

Blood-type-related information and 10 health categories

Includes AIM (CD5L) exon 3 analysis.

04 / PERSONAL REPORT

Individual Results Report

A personalized report and guidance on your cat’s care, based on blood and genetic test results analyzed and interpreted by specialists.

Apply for Your Cat

Our research team will review your application and contact you about whether your cat is eligible.

What Procedures
Will My Cat Undergo?

Blood Collection at Two Visits

Blood is collected at two visits: on day 0 and at the final examination. A veterinarian checks your cat’s condition, and collection is performed in a way similar to routine blood testing.

Cheek Swab for Genetic Testing

For genetic testing, cells are collected with a swab of the inside of your cat’s cheek.

Your cat’s condition and stress level are taken into account throughout all procedures.

Research Team and Participating Clinics

Study Design and Leadership: Hochul Shin
Study Design and Leadership

Hochul ShinPhD

PhD in Biological Sciences, KAIST

  • Former senior researcher at a pharmaceutical company
  • Research lead at MomoGroup and Greycoat Research
Academic Adviser: Arai Toshiro
Academic Adviser

Arai ToshiroDVM, PhD

Professor Emeritus, Nippon Veterinary and Life Science University

Clinical Adviser: Kobayashi Motoo
Clinical Adviser

Kobayashi MotooDVM, PhD

Director, Seijo Kobayashi Animal Hospital

Study organizersMomoGroup Co., Ltd.Greycoat Research

Participating Veterinary Clinics

Your clinic and appointment schedule will be arranged individually after participation is confirmed.

Seoul, South Korea

Taeneung Cat Specialty Animal Hospital

Seoul, South Korea

World Pet Animal Hospital

Seongnam, South Korea

Soseol Cat Hospital

Other locations in South Korea

Collaborating veterinary clinics

FAQ

Frequently Asked Questions

Have a question about the study? Contact our research team.

Contact the Research Team
Can my cat continue prescribed medications or a prescription diet?

Yes. Do not stop or change your cat’s existing treatment on your own to take part in the study. Tell us about all prescribed medications and prescription diets when you apply.

Can my cat participate while taking other supplements?

Please list all supplements your cat currently receives. We will review whether they could affect the study results and provide individual guidance.

Can I open the capsules and mix the contents into food?

No. To keep study conditions consistent, capsules must be given whole. Do not open them or mix their contents into food.

What if I miss a dose?

Do not give a double dose on your own. Let the research team know.

What if my cat vomits or spits out a capsule?

Do not give another dose on your own. Tell the research team so they can review your cat’s condition and what happened before advising you.

Can I apply for more than one cat?

Yes. Each cat will be assessed individually for eligibility. If more than one cat participates, you must be able to keep separate supplementation and health records for each cat.

What if I notice a change in my cat during the study?

Tell the research team if you notice changes in your cat’s usual condition, such as appetite or activity. Do not wait for the next health questionnaire. If you think your cat needs veterinary care, prioritize a veterinary visit over the study schedule.

Could future studies include cats in other countries?

Future studies may offer opportunities for cats and their families in additional countries and regions. Eligibility and locations will depend on each study’s design and local research arrangements. The current study involves two in-person visits to participating veterinary clinics in South Korea.

If you are interested in future studies, we would be glad to hear from you at program@greycoatresearch.com.

THE CURRENT GCR-002 STUDY

Explore the Current Study

Applications are welcome for healthy cats and cats with CKD at IRIS stages 1–3. Our research team will review your cat’s health, current treatment, and participation requirements before advising you about eligibility.

The current study takes place at participating veterinary clinics in South Korea and requires two in-person visits.

Healthy cats and IRIS stages 1–3 · 60 cats

Apply for Your Cat

Our research team will review your application and contact you about whether your cat is eligible.

Cats are selected based on study criteria,
not the order in which applications are received.

Contact

FUTURE RESEARCH

Looking Ahead to Future Studies

Following our research from outside South Korea? Future studies may include a broader range of cats and locations. Participation requirements will depend on each study’s design and research arrangements.

For questions or to share your interest in future studies, contact program@greycoatresearch.com.

Contact the Research Team